GGrantIndex
Sort

65,743 grants matching single cell sequencing

Mechanisms that regulate erythroid differentiation of hematopoietic stem cells

$612,835
Daisuke Nakada · Baylor College Of Medicine · R01 · FY2022 · HL

Molecular pathogenesis of blastomycosis

$612,804
Bruce Steven Klein · University Of Wisconsin-Madison · R37 · FY2025 · AI

Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis

$612,784
Maria Ciofani · Duke University · R01 · FY2024 · AI

Single cell transcriptomic study of alcohol use

$612,749
Edwin Van Den Oord · Virginia Commonwealth University · R01 · FY2024 · AA

Strategies for Cancer Vaccine Development: Preclinical Studies

$612,693
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Genomic Predictors of Placebo response in Phase II AUD trials

$612,688
Anup Mahurkar · University Of Maryland Baltimore · R01 · FY2022 · AA

Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens

$612,573
Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2023 · AI

Genomic Enhancers at 8q24 and Prostate Cancer

$612,476
Gerhard A Coetzee · University Of Southern California · R01 · FY2012 · CA

Identification of Genetic and Molecular Bases of Derived Phenotypes in Primate Brain Development

$612,464
Nenad Sestan · Yale University · R01 · FY2021 · HG

In search of an HBV cure: novel model systems and targets

$612,444
Charles M. Rice · Rockefeller University · R01 · FY2019 · AI

Mechanisms of Vasomotion-mediated Perivascular Clearance in Cerebral Amyloid Angiopathy

$612,443
Susanne Janneke Van Veluw · Massachusetts General Hospital · R01 · FY2023 · NS

Mechanisms of Vasomotion-mediated Perivascular Clearance in Cerebral Amyloid Angiopathy

$612,443
Susanne Janneke Van Veluw · Massachusetts General Hospital · R01 · FY2024 · NS

Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics

$612,394
David Yu Zhang · Rice University · R01 · FY2018 · CA

Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics

$612,394
David Yu Zhang · Rice University · R01 · FY2020 · CA

Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics

$612,394
David Yu Zhang · Rice University · R01 · FY2017 · CA

Immune Responses To HIV And Other Pathogens

$612,355
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Immune Responses To HIV And Other Pathogens

$612,354
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2023 · EB

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2022 · EB

Dissecting a novel tumor-promoting axis in cholangiocarcinoma

$612,322
Daniela Sia · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Dissecting a novel tumor-promoting axis in cholangiocarcinoma

$612,322
Daniela Sia · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD)

$612,305
Robert P Schleimer · Northwestern University At Chicago · R01 · FY2021 · AI

Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer

$612,300
Peter Poon-Hang Lee · Beckman Research Institute/City Of Hope · U01 · FY2022 · CA

Impact of novel enhancers on Igh repertoire diversity

$612,259
Amy L. Kenter · University Of Illinois At Chicago · R01 · FY2023 · AI

Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut

$612,247
Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2022 · AI